sivopixant (S-600918) / Shionogi 
Welcome,         Profile    Billing    Logout  

1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
sivopixant (S-600918) / Shionogi
2019-002283-27: Research study of an investigational drug called S-600918 for refractory chronic cough, defined as chronic cough that continues after treatment for the disease(s) causing the cough or as unexplained chronic cough for which the disease has not been determined.

Not yet recruiting
2
372
Europe
S-600918, Film-coated tablet
Shionogi B.V., Shionogi & Co., Ltd
Refractory chronic cough, Chronic cough which continues without enough improvement after treatment for the disease(s) causing the cough, or as an unexplained cough, for which the disease has not been determined., Body processes [G] - Circulatory and Respiratory Physiological Phenomena [G09]
 
 

Download Options